SANGUI BIOTECH INTERNATIONAL INC SEC Filings

Filed On	Filing
03 Jul 2025	REVOKED
12 May 2023	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
07 Feb 2023	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
10 Nov 2022	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
03 Nov 2022	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
28 Sep 2022	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-K SEC FILING
12 Aug 2022	Form 5: Striepe Thomas, Director Holds 1,350,000 shares of Common Stock
12 Aug 2022	Form 5: Schmelz Hubertus, Director Holds 17,606,481 shares of Common Stock
16 May 2022	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
11 Feb 2022	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
12 Nov 2021	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
18 Oct 2021	Form 4: Schmelz Hubertus, Director Acquired 1,200,000 shares (Open Market Sale) ($23.6K)
28 Sep 2021	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-K SEC FILING
13 Aug 2021	Form 5: Schmelz Hubertus, Director Holds 18,806,481 shares of Common Stock
13 Aug 2021	Form 5: Striepe Thomas, Director Holds 1,350,000 shares of Common Stock
07 Jun 2021	UPLOAD
07 May 2021	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
07 May 2021	SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING
30 Apr 2021	10-K/A
29 Apr 2021	10-K/A

Comments